
Naira-Backed Health: NSIA and IFC Ink $154.1 Million Oncology & Diagnostic Deal
By Hussaini Umar | Analysis of the MedServe Nationwide Expansion
$154.1 Million
Total Expansion Value
Targeting radiotherapy, CT/MRI hubs, and cardiac labs across Nigeria.
₦14.2 Billion
IFC Naira Financing
Structured in local currency to mitigate FX risks.
1,300+
Total Human Impact
800 direct jobs created and 500 professionals trained in oncology/cardiology.
The Nigeria Sovereign Investment Authority (NSIA) and the International Finance Corporation (IFC) have reached a strategic inflection point in the funding of Nigeria’s healthcare sector. By deploying naira-denominated financing, the partnership aims to expand advanced medical services via MedServe, the NSIA’s healthcare subsidiary.
De-Risking the Health Sector
Historically, private investment in Nigerian healthcare has been constrained by Foreign Exchange (FX) risks. Because medical equipment is imported in USD but revenues are earned in Naira, currency devaluation often collapses business models. This agreement addresses that “Critical Gap” by providing long-tenor local currency funding, allowing MedServe to scale without the shadow of FX volatility.
Technological Infrastructure and Access
The program will establish more than a dozen centers equipped with cutting-edge medical technologies, including:
- Oncology: Linear accelerators and radiotherapy enabled cancer care.
- Diagnostics: Advanced Digital Pathology, CT, and MRI scanners.
- Cardiology: Cardiac catheterisation laboratories for heart-related interventions.
By co-locating these facilities within public hospitals, MedServe maximizes capital efficiency and ensures that underserved communities gain access to high-tier medical care without the need for multi-billion dollar “medical tourism” spending abroad.
